Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,891.00p
   
  • Change Today:
      16.00p
  • 52 Week High: 2,205.00p
  • 52 Week Low: 1,722.00p
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 414,106
  • Market Cap: £4,195.85m
  • RiskGrade: 125

ShareCast News

Hikma makes 'encouraging' start to year, shareho... 18-May-2018 ShareCast
Hikma's US subsidiary launches cancer drug 03-May-2018 ShareCast
Hikma launches generic injectable version of Zin... 20-Apr-2018 ShareCast
Hikma subsidiary launches palonosetron injection... 29-Mar-2018 ShareCast
Hikma US unit launches anti-HIV tablet 20-Mar-2018 ShareCast
Thursday broker round-up 15-Mar-2018 ShareCast
Hikma FY numbers hit by US impairment charge 14-Mar-2018 ShareCast
Boost for GSK as Hikma, Vectura expect 2020 laun... 12-Mar-2018 ShareCast
Thursday broker round-up 01-Mar-2018 ShareCast
Siggi Olafsson installed as new CEO at Hikma 20-Feb-2018 ShareCast
Hikma appoints Surendera Tyagi as chief scientif... 15-Jan-2018 ShareCast
Hikma downgraded by Jefferies on turnaround chal... 10-Jan-2018 ShareCast
Hikma Pharmaceuticals agrees licensing deal with... 19-Dec-2017 ShareCast
Hikma launches migraine injection treatment 13-Dec-2017 ShareCast
Hikma Pharmaceutical purchases $3m worth of prod... 14-Nov-2017 ShareCast
Hikma Pharmaceuticals cuts generics guidance again 09-Nov-2017 ShareCast
Vectura sinks to four-year low as generic Advair... 09-Nov-2017 ShareCast
Hikma Pharmaceuticals US subsidiary launches GER... 30-Oct-2017 ShareCast
Thursday broker round-up 24-Aug-2017 ShareCast
Tuesday broker round-up 22-Aug-2017 ShareCast
Monday broker round-up 21-Aug-2017 ShareCast
Jefferies ups Hikma to 'hold' as it removes gene... 21-Aug-2017 ShareCast
HSBC slashes target price on Hikma Pharmaceuticals 18-Aug-2017 ShareCast
Thursday broker round-up 17-Aug-2017 ShareCast
Hikma Pharma trims guidance as generic Advair ta... 17-Aug-2017 ShareCast
Friday broker round-up 11-Aug-2017 ShareCast
Wednesday broker round-up 02-Aug-2017 ShareCast
Wednesday broker round-up 28-Jun-2017 ShareCast
Tuesday broker round-up 27-Jun-2017 ShareCast
Hikma to split US business into two divisions 26-Jun-2017 ShareCast
Tuesday broker round-up 23-May-2017 ShareCast
Hikma updates revenue guidance after US delays a... 19-May-2017 ShareCast
Wednesday broker round-up 17-May-2017 ShareCast
Jefferies downgrades Hikma on generic Advair del... 17-May-2017 ShareCast
JP Morgan slashes target price on Hikma Pharmace... 12-May-2017 ShareCast
Hikma and Vectura disappointed by FDA's generic ... 11-May-2017 ShareCast
London close: FTSE 'forgettable' on Monday as UK... 10-Apr-2017 ShareCast
Monday broker round-up 10-Apr-2017 ShareCast
London close: FTSE meanders to mixed close with ... 06-Apr-2017 ShareCast
Hikma settles Xyrem patent dispute with Jazz Pha... 06-Apr-2017 ShareCast
London close: FTSE drifts lower ahead of pivotal... 24-Mar-2017 ShareCast
London close: Surge in UK inflation sees sterlin... 21-Mar-2017 ShareCast
London close: Miners rocket higher on Fed rate h... 16-Mar-2017 ShareCast
Thursday broker round-up 16-Mar-2017 ShareCast
JP Morgan downgrades Hikma Pharmaceuticals on ge... 16-Mar-2017 ShareCast
London close: FTSE clings to minor resources-led... 15-Mar-2017 ShareCast
Hikma Pharmaceuticals impresses despite profits ... 15-Mar-2017 ShareCast
London close: FTSE 100 rises amid BP bid specula... 10-Mar-2017 ShareCast
Hikma US unit launches anti-depression tablets 10-Mar-2017 ShareCast
Hikma signs Easyhaler deal with Orion 13-Feb-2017 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,891.00p
Change Today 16.00p
% Change 0.85 %
52 Week High 2,205.00p
52 Week Low 1,722.00p
Volume 414,106
Shares Issued 221.89m
Market Cap £4,195.85m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.07% below the market average48.07% below the market average48.07% below the market average48.07% below the market average48.07% below the market average
1.96% above the sector average1.96% above the sector average1.96% above the sector average1.96% above the sector average1.96% above the sector average
Price Trend
44.88% above the market average44.88% above the market average44.88% above the market average44.88% above the market average44.88% above the market average
69.81% above the sector average69.81% above the sector average69.81% above the sector average69.81% above the sector average69.81% above the sector average
Income
11.05% above the market average11.05% above the market average11.05% above the market average11.05% above the market average11.05% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
31.5% below the market average31.5% below the market average31.5% below the market average31.5% below the market average31.5% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 21-Mar-24 10-Aug-23
Paid 03-May-24 15-Sep-23
Amount 47.00¢ 25.00¢

Trades for 28-Jun-2024

Time Volume / Share Price
16:37 2,829 @ 1,891.00p
16:35 2,539 @ 1,891.00p
16:35 294 @ 1,891.00p
16:35 273,431 @ 1,891.00p
16:35 300 @ 1,891.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page